<p>NewEdge Advisors LLC 在最近向证券交易委员会提交的 13F 表格中表示，在第二季度将其在美敦力 PLC (NYSE:MDT - 免费报告) 的持仓削减了 37.4%。该公司在季度内出售了 81,417 股后，持有 136,203 股这家医疗科技公司的股票。截至其最近向证券交易委员会提交的文件，美敦力的持股价值为 11,873,000 美元。</p>
<ul>
<li>美敦力股票找到支撑——现在正在获得动能</li>
</ul>
<p>其他机构投资者也对该公司的股份进行了增持或减持。Gilbert &amp; Cook Inc. 在第二季度将其在美敦力的股份增加了 1.9%。Gilbert &amp; Cook Inc. 目前持有 6,103 股这家医疗科技公司的股票，价值 532,000 美元，此前在上个季度增持了 114 股。Red Spruce Capital LLC 在第二季度将其在美敦力的持股增加了 0.5%。Red Spruce Capital LLC 目前持有 23,707 股这家医疗科技公司的股票，价值 2,067,000 美元，此前在该期间增持了 118 股。Certior Financial Group LLC 在第一季度将其在美敦力的持仓增加了 3.7%。Certior Financial Group LLC 目前持有 3,450 股这家医疗科技公司的股票，价值 310,000 美元，此前在上个季度增持了 122 股。Cary Street Partners Investment Advisory LLC 在第二季度将其在美敦力的持股增加了 6.0%。Cary Street Partners Investment Advisory LLC 目前持有 2,191 股这家医疗科技公司的股票，价值 191,000 美元，此前在该期间增持了 124 股。最后，PrairieView Partners LLC 在第二季度将其在美敦力的股份增加了 3.6%。PrairieView Partners LLC 目前持有 3,726 股这家医疗科技公司的股票，价值 324,000 美元，此前在上个季度增持了 128 股。对冲基金和其他机构投资者持有该公司 82.06% 的股份。</p>
<h2>分析师设定新目标价</h2>
<p>MDT 最近成为多份分析师报告的主题。高盛集团在 11 月 19 日的报告中将美敦力的目标价设定为 111.00 美元，并给予该公司 “中性” 评级。巴克莱在 11 月 20 日的报告中将美敦力的目标价从 109.00 美元上调至 111.00 美元，并给予该股票 “增持” 评级。阿古斯在 8 月 26 日的研究报告中将美敦力的目标价从 105.00 美元上调至 115.00 美元，并给予该公司 “买入” 评级。桑福德·C·伯恩斯坦在 11 月 19 日的研究报告中将美敦力的目标价设定为 111.00 美元。最后，斯蒂费尔·尼古拉斯在 10 月 9 日的报告中将美敦力的目标价从 90.00 美元上调至 105.00 美元，并给予该股票 “持有” 评级。一位研究分析师给予该股票 “强烈买入” 评级，十三位给予 “买入” 评级，十二位给予 “持有” 评级。根据 MarketBeat 的数据，美敦力目前的共识评级为 “适度买入”，共识目标价为 110.44 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
<p><strong>获取我们最新的 MDT 股票报告</strong></p>
<h2>美敦力股票下跌 1.0%</h2>
<p>美敦力股票周五开盘价为 99.77 美元。该公司的债务与股本比率为 0.57，流动比率为 2.42，速动比率为 1.80。该公司的 50 日移动平均线为 97.23 美元，200 日移动平均线为 92.66 美元。该公司的市值为 1,279.1 亿美元，市盈率为 26.89，PEG 比率为 2.65，贝塔值为 0.71。美敦力 PLC 的一年低点为 79.29 美元，一年高点为 106.33 美元。</p>
<ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
<p>美敦力 (NYSE:MDT - 获取免费报告) 最近在 11 月 18 日星期二发布了季度财报。这家医疗科技公司报告季度每股收益为 1.36 美元，超出市场共识预期的 1.31 美元，超出幅度为 0.05 美元。美敦力的净利润率为 13.71%，股本回报率为 14.86%。该公司在本季度的收入为 89.6 亿美元，而分析师预期为 88.6 亿美元。在去年同期，该公司每股收益为 1.26 美元。美敦力的季度收入同比增长 6.6%。美敦力已将其 2026 财年的指导目标设定为 5.620-5.660 每股收益。整体来看，卖方分析师预计美敦力 PLC 本财年将发布 5.46 美元的每股收益。</p>
<h2>美敦力分红公告</h2>
<p>该公司最近还披露了一项季度分红，将于 1 月 16 日星期五支付。12 月 26 日的登记投资者将获得每股 0.71 美元的分红。这相当于每年 2.84 美元的分红，收益率为 2.8%。该分红的除息日期为 12 月 26 日。美敦力的分红支付比率 (DPR) 为 76.55%。</p>
<h2>关于美敦力</h2>
<p>(免费报告)</p>
<p>美敦力 plc 开发、制造和销售基于设备的医疗疗法，面向全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过美敦力</li>
<li>如何计算退休收入：MarketBeat 的计算器</li>
<li>2026 年需避免的三只最近被下调的股票</li>
<li>如何有效使用 MarketBeat 评级筛选器</li>
<li>芯片热潮回归：三只有望大幅上涨的股票</li>
<li>股票拆分，真的会影响投资者吗？</li>
<li>甲骨文股票遭重创：为何其 AI 管道可能推动 2026 年的反弹</li>
</ul>
<p><strong>想知道其他对冲基金持有 MDT 的情况吗？</strong> 请访问 HoldingsChannel.com 获取 Medtronic PLC (NYSE:MDT - 免费报告) 的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Medtronic 吗？</h2>
<p>在考虑 Medtronic 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Medtronic 并不在名单上。</p>
<p>虽然 Medtronic 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美敦力

<p>NewEdge Advisors LLC 在第二季度减少了对美敦力（Medtronic PLC）的持股，减持幅度为 37.4%，出售了 81,417 股。该公司目前持有 136,203 股，市值为 1187 万美元。其他机构投资者也调整了在美敦力的持仓。分析师设定了新的价格目标，普遍评级为 “适度买入”，目标价格为 110.44 美元。美敦力的股票开盘价为 99.77 美元，市值为 1279.1 亿美元。该公司报告第二季度每股收益为 1.36 美元，超出预期，营收为 89.6 亿美元，同比增长 6.6%</p>

<p>NewEdge Advisors LLC trimmed its position in Medtronic PLC (NYSE:MDT - Free Report) by 37.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The firm owned 136,203 shares of the medical technology company's stock after selling 81,417 shares during the quarter. NewEdge Advisors LLC's holdings in Medtronic were worth $11,873,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>NewEdge Advisors LLC 在最近向证券交易委员会提交的 13F 表格中表示，在第二季度将其在美敦力 PLC (NYSE:MDT - 免费报告) 的持仓削减了 37.4%。该公司在季度内出售了 81,417 股后，持有 136,203 股这家医疗科技公司的股票。截至其最近向证券交易委员会提交的文件，美敦力的持股价值为 11,873,000 美元。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到支撑——现在正在获得动能</li>
</ul>
</div><p>Other institutional investors have also added to or reduced their stakes in the company. Gilbert &amp; Cook Inc. raised its stake in shares of Medtronic by 1.9% during the second quarter. Gilbert &amp; Cook Inc. now owns 6,103 shares of the medical technology company's stock valued at $532,000 after acquiring an additional 114 shares during the last quarter. Red Spruce Capital LLC increased its holdings in Medtronic by 0.5% during the 2nd quarter. Red Spruce Capital LLC now owns 23,707 shares of the medical technology company's stock valued at $2,067,000 after purchasing an additional 118 shares during the period. Certior Financial Group LLC raised its position in Medtronic by 3.7% during the 1st quarter. Certior Financial Group LLC now owns 3,450 shares of the medical technology company's stock valued at $310,000 after purchasing an additional 122 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its holdings in Medtronic by 6.0% in the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 2,191 shares of the medical technology company's stock worth $191,000 after buying an additional 124 shares during the period. Finally, PrairieView Partners LLC grew its position in shares of Medtronic by 3.6% in the 2nd quarter. PrairieView Partners LLC now owns 3,726 shares of the medical technology company's stock worth $324,000 after buying an additional 128 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.</p>
<div class="lb-trans"><p>其他机构投资者也对该公司的股份进行了增持或减持。Gilbert &amp; Cook Inc. 在第二季度将其在美敦力的股份增加了 1.9%。Gilbert &amp; Cook Inc. 目前持有 6,103 股这家医疗科技公司的股票，价值 532,000 美元，此前在上个季度增持了 114 股。Red Spruce Capital LLC 在第二季度将其在美敦力的持股增加了 0.5%。Red Spruce Capital LLC 目前持有 23,707 股这家医疗科技公司的股票，价值 2,067,000 美元，此前在该期间增持了 118 股。Certior Financial Group LLC 在第一季度将其在美敦力的持仓增加了 3.7%。Certior Financial Group LLC 目前持有 3,450 股这家医疗科技公司的股票，价值 310,000 美元，此前在上个季度增持了 122 股。Cary Street Partners Investment Advisory LLC 在第二季度将其在美敦力的持股增加了 6.0%。Cary Street Partners Investment Advisory LLC 目前持有 2,191 股这家医疗科技公司的股票，价值 191,000 美元，此前在该期间增持了 124 股。最后，PrairieView Partners LLC 在第二季度将其在美敦力的股份增加了 3.6%。PrairieView Partners LLC 目前持有 3,726 股这家医疗科技公司的股票，价值 324,000 美元，此前在上个季度增持了 128 股。对冲基金和其他机构投资者持有该公司 82.06% 的股份。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>MDT has been the subject of a number of recent analyst reports. The Goldman Sachs Group set a $111.00 target price on Medtronic and gave the company a &#34;neutral&#34; rating in a report on Wednesday, November 19th. Barclays upped their price objective on shares of Medtronic from $109.00 to $111.00 and gave the stock an &#34;overweight&#34; rating in a report on Thursday, November 20th. Argus lifted their target price on shares of Medtronic from $105.00 to $115.00 and gave the company a &#34;buy&#34; rating in a research note on Tuesday, August 26th. Sanford C. Bernstein set a $111.00 price target on shares of Medtronic in a research report on Wednesday, November 19th. Finally, Stifel Nicolaus raised their price objective on shares of Medtronic from $90.00 to $105.00 and gave the stock a &#34;hold&#34; rating in a report on Thursday, October 9th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and twelve have given a Hold rating to the company's stock. According to MarketBeat, Medtronic presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $110.44.</p>
<div class="lb-trans"><p>MDT 最近成为多份分析师报告的主题。高盛集团在 11 月 19 日的报告中将美敦力的目标价设定为 111.00 美元，并给予该公司 “中性” 评级。巴克莱在 11 月 20 日的报告中将美敦力的目标价从 109.00 美元上调至 111.00 美元，并给予该股票 “增持” 评级。阿古斯在 8 月 26 日的研究报告中将美敦力的目标价从 105.00 美元上调至 115.00 美元，并给予该公司 “买入” 评级。桑福德·C·伯恩斯坦在 11 月 19 日的研究报告中将美敦力的目标价设定为 111.00 美元。最后，斯蒂费尔·尼古拉斯在 10 月 9 日的报告中将美敦力的目标价从 90.00 美元上调至 105.00 美元，并给予该股票 “持有” 评级。一位研究分析师给予该股票 “强烈买入” 评级，十三位给予 “买入” 评级，十二位给予 “持有” 评级。根据 MarketBeat 的数据，美敦力目前的共识评级为 “适度买入”，共识目标价为 110.44 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on MDT</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 MDT 股票报告</strong></p>
</div><h2>Medtronic Stock Down 1.0%</h2>
<div class="lb-trans"><h2>美敦力股票下跌 1.0%</h2>
</div><p>Shares of Medtronic stock opened at $99.77 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.42 and a quick ratio of 1.80. The company has a 50-day moving average of $97.23 and a 200 day moving average of $92.66. The firm has a market cap of $127.91 billion, a price-to-earnings ratio of 26.89, a PEG ratio of 2.65 and a beta of 0.71. Medtronic PLC has a 1 year low of $79.29 and a 1 year high of $106.33.</p>
<div class="lb-trans"><p>美敦力股票周五开盘价为 99.77 美元。该公司的债务与股本比率为 0.57，流动比率为 2.42，速动比率为 1.80。该公司的 50 日移动平均线为 97.23 美元，200 日移动平均线为 92.66 美元。该公司的市值为 1,279.1 亿美元，市盈率为 26.89，PEG 比率为 2.65，贝塔值为 0.71。美敦力 PLC 的一年低点为 79.29 美元，一年高点为 106.33 美元。</p>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last posted its quarterly earnings data on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, topping the consensus estimate of $1.31 by $0.05. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The business had revenue of $8.96 billion for the quarter, compared to analyst estimates of $8.86 billion. During the same quarter in the previous year, the firm posted $1.26 earnings per share. Medtronic's quarterly revenue was up 6.6% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. As a group, sell-side analysts anticipate that Medtronic PLC will post 5.46 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>美敦力 (NYSE:MDT - 获取免费报告) 最近在 11 月 18 日星期二发布了季度财报。这家医疗科技公司报告季度每股收益为 1.36 美元，超出市场共识预期的 1.31 美元，超出幅度为 0.05 美元。美敦力的净利润率为 13.71%，股本回报率为 14.86%。该公司在本季度的收入为 89.6 亿美元，而分析师预期为 88.6 亿美元。在去年同期，该公司每股收益为 1.26 美元。美敦力的季度收入同比增长 6.6%。美敦力已将其 2026 财年的指导目标设定为 5.620-5.660 每股收益。整体来看，卖方分析师预计美敦力 PLC 本财年将发布 5.46 美元的每股收益。</p>
</div><h2>Medtronic Dividend Announcement</h2>
<div class="lb-trans"><h2>美敦力分红公告</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic's dividend payout ratio (DPR) is 76.55%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度分红，将于 1 月 16 日星期五支付。12 月 26 日的登记投资者将获得每股 0.71 美元的分红。这相当于每年 2.84 美元的分红，收益率为 2.8%。该分红的除息日期为 12 月 26 日。美敦力的分红支付比率 (DPR) 为 76.55%。</p>
</div><h2>About Medtronic</h2>
<div class="lb-trans"><h2>关于美敦力</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p>
<div class="lb-trans"><p>美敦力 plc 开发、制造和销售基于设备的医疗疗法，面向全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>How to Calculate Retirement Income: MarketBeat’s Calculator</li>
<li>3 Recently Downgraded Stocks to Avoid in 2026</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li>
<li>Stock Splits, Do They Really Impact Investors?</li>
<li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过美敦力</li>
<li>如何计算退休收入：MarketBeat 的计算器</li>
<li>2026 年需避免的三只最近被下调的股票</li>
<li>如何有效使用 MarketBeat 评级筛选器</li>
<li>芯片热潮回归：三只有望大幅上涨的股票</li>
<li>股票拆分，真的会影响投资者吗？</li>
<li>甲骨文股票遭重创：为何其 AI 管道可能推动 2026 年的反弹</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对冲基金持有 MDT 的情况吗？</strong> 请访问 HoldingsChannel.com 获取 Medtronic PLC (NYSE:MDT - 免费报告) 的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Medtronic 吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Medtronic 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Medtronic 并不在名单上。</p>
</div><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Medtronic 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

NewEdge Advisors LLC 出售了 81,417 股美敦力公司（Medtronic PLC）的股票，代码为$MDT